LevinA., BakrisG.L., MolitchM.Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int2007; 71(1): 31–8.
2.
HaddadJGJr., WalgateJ.25-Hydroxyvitamin D transport in human plasma. Isolation and partial characterization of calcifidiol-binding protein. J Biol Chem1976; 251(16): 4803–9.
3.
CookeN.E., HaddadJ.G.Vitamin D binding protein (Gc-globulin). Endocr Rev1989; 10(3): 294–307. Review.
BoyceB.F., XingL.Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res Ther2007; 9(suppl 1): S1. Review.
8.
Van AbelM., HoenderopJ.G., van der KempA.W., FriedlaenderM.M., van LeeuwenJ.P., BindelsR.J.Coordinated control of renal Ca(2+) transport proteins by parathyroid hormone. Kidney Int2005; 68(4): 1708–21.
9.
BacicD., WagnerC.A., HernandoN., KaisslingB., BiberJ., MurerH.Novel aspects in regulated expression of the renal type IIa Na/Pi-cotransporter. Kidney Int2004; 91(suppl): S5–12. Review.
10.
ForsterI.C., HernandoN., BiberJ., MurerH.Proximal tubular handling of phosphate: A molecular perspective. Kidney Int2006; 70(9): 1548–59.
11.
KilavR., BellO., LeS.Y., SilverJ., Naveh-ManyT.The parathyroid hormone mRNA 3′-untranslated region AU-rich element is an unstructured functional element. J Biol Chem2004; 279(3): 2109–16.
12.
BrownA.J., DussoA., Lopez-HilkerS., Lewis-FinchJ., GroomsP., SlatopolskyE.1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int1989; 35(1): 19–23.
13.
BrownA.J., RitterC.S., FinchJ.L., SlatopolskyE.A.Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Kidney Int1999; 55(4): 1284–92.
14.
SlatopolskyE., FinchJ., ClayP., MartinD., SicardG., SingerG., GaoP., CantorT., DussoA.A novel mechanism for skeletal resistance in uremia. Kidney Int2000; 58(2): 753–61.
15.
QuarlesL.D.Evidence for a bone-kidney axis regulating phosphate homeostasis. J Clin Invest2003; 112(5): 642–6.
RazzaqueM.S., LanskeB.Hypervitaminosis D and pre-mature aging: lessons learned from Fgf23 and Klotho mutant mice. Trends Mol Med2006; 12(7): 298–305.
18.
MazzaferroS.Is there any role predictable for bone morphogenetic protein-7 in nephrology?G Ital Nefrol2006; 23(2): 129–37.
19.
LundK.J., DaviesM.R., BrownA.J., HruskaK.A.Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model. J Am Soc Nephrol2004; 15: 359–69.
20.
MathewS., DaviesM., LundR., SaabG., HruskaK.A.Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease. Eur J Clin Invest2006; 36(suppl 2): S43–50.
